LONDON, July 5 (Reuters) – Britain is close to agreeing a 500 million pound ($624 million) supply handle Sanofi and GlaxoSmithKline for 60 million doses of their prospective COVID-19 vaccine, the Sunday Times reported.
The newspaper said that Britain was thinking about taking an option to buy the vaccine ought to it operate in human trials, which are because of start in September.
$ 1 = 0.8011 pounds
Reporting by Alistair Smout; Modifying by Elaine Hardcastle
Our Standards: The Thomson Reuters Trust Principles.
Comments
Post a Comment